T · 7634.T
Hoshi Iryo-Sanki Co., Ltd.
- Sector
- Healthcare · Medical - Equipment & Services
- Headquarters
- Tokyo 121-0836
- Website
- hosi.co.jp
Price · as of 2025-03-31
$5,150.00
Market cap 16.24B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $6,414.37 | +24.55% |
| Intrinsic Value(DCF) | $3,787.54 | -26.46% |
| Graham-Dodd Method(GD) | $7,208.12 | +39.96% |
| Graham Formula(GF) | $4,801.98 | -6.76% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $3,687.58 | ||||
| 2021 | $3,352.35 | $3,600.41 | $2,818.33 | $4,974.32 | $5,121.94 |
| 2022 | $3,300.17 | $3,839.92 | $2,820.65 | $5,672.38 | $5,723.97 |
| 2023 | $3,870.90 | $5,661.33 | $3,054.50 | $6,050.45 | $6,283.04 |
| 2024 | $4,983.57 | $6,750.14 | $3,486.80 | $6,767.55 | $6,768.40 |
| 2025 | $4,449.99 | $6,414.37 | $3,370.57 | $7,208.12 | $4,801.98 |
AI valuation
Our deep-learning model estimates Hoshi Iryo-Sanki Co., Ltd.'s (7634.T) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $6,414.37
- Current price
- $5,150.00
- AI upside
- +24.55%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$3,787.54
-26.46% upside
Graham-Dodd
$7,208.12
+39.96% upside
Graham Formula
$4,801.98
-6.76% upside
About Hoshi Iryo-Sanki Co., Ltd.
Hoshi Iryo-Sanki Co., Ltd. manufactures and sells pharmaceutical medical oxygen and nitrous oxides in Japan. It operates in five segments: Medical Gas-Related Business; Home Healthcare-Related Business; Medical Gas Equipment Construction-Related Business; Nursing-Care Related Business; and Facilities Nursing-Related Business. The Medical Gas-Related Business segment sells medical oxygen gas, anesthetic gas, and other medical gas. The Home Healthcare-Related Business segment rents oxygen concentrators for home oxygen therapy; and equipment for continuous positive airway pressure, home ventilators, etc. The Medical Gas Equipment Construction-Related Business segment designs and constructs medical gas piping construction, as well as maintenance and inspection of medical gas piping equipment. The Nursing-Care Related Business segment offers rental and sale of nursing care related products and equipment, home renovation, home-visit nursing, and in-home nursing care support services. The Facilities Nursing-Related Business segment operates fee-based nursing homes and day care facilities, as well as related operations. The company was founded in 1960 and is headquartered in Tokyo, Japan.
- CEO
- Yukio Hoshi
- Employees
- 486
- Beta
- 0.44
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($3,787.54 ÷ $5,150.00) − 1 = -26.46% (DCF, example).